University of Alberta
BioMark Diagnostics Nabs Canadian Funding for Lung Cancer Liquid Biopsy
The company is developing a metabolomic assay for early detection of lung cancer with academic collaborators at the University of Alberta.
U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test
BioMark Diagnostics has been collaborating on the test with the Metabolomics Innovation Centre at the University of Alberta since early 2015.
CareDx, NanoString Collaborate to Develop Organ Transplant Rejection Test
CareDx will use NanoString's new Human Organ Transplant panel to develop HistoMap, a gene expression profiling test to identify allograft rejection.
Researchers in Nigeria are developing a handheld diagnostic device for identifying high-risk colorectal cancer patients in low-resource environments.
The mobile approach enables stroke patients to be assessed within the three-hour window for stroke treatment.